Mivac Development grants Synthon a license to multiple sclerosis (MS) candidates discovered by the partners

Mivac Development AB

Sweden / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Synthon B.V.

the Netherlands / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced